REMINDER: Our user survey closes on Friday, please submit your responses here.
This would not be rebalancing, holding in Synergy too small to make a difference to their fund. Strange if they’re taking risk off the table, that makes no sense at all, again given their small holding in Synergy. Odd to say the least
I’ve said before and before, we are missing the boat here, the tests have taken an unexplainable long time. No idea why, maybe small pharma up against giants, hope not, but if above drug is 80% effective at low cost, why would anyone pay xxxx for Syn?
I’ve been in for 2 years, decent pot, but not a problem if it crashes ( only invest in Aim what you can afford to loose), my glass is always half full, but I’m beginning to doubt the upside